B细胞-话题@MedSci

#B细胞#

314篇内容 | 6306人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1273326, encodeId=da7112e332653, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=【2019 CSCO】国内白血病·淋巴瘤专场：聚焦淋巴瘤治疗前沿，BTK抑制剂在B细胞淋巴瘤中应用前景广阔, objectType=article, longId=180451, objectId=021e180451ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=021e180451ba, replyNumber=0, likeNumber=75, createdTime=2019-10-05, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=021e180451ba, moduleTitle=【2019 CSCO】国内白血病·淋巴瘤专场：聚焦淋巴瘤治疗前沿，BTK抑制剂在B细胞淋巴瘤中应用前景广阔, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=021e180451ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273325, encodeId=f19812e332573, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估, objectType=article, longId=180400, objectId=2b0b180400c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0b180400c6, replyNumber=0, likeNumber=123, createdTime=2019-10-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0b180400c6, moduleTitle=Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0b180400c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273324, encodeId=20bf12e332475, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Sci tranal med：BAFF-R靶向CAR T细胞疗法可克服B细胞恶性肿瘤的CD19抗原缺失, objectType=article, longId=180381, objectId=e0141803814a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0141803814a, replyNumber=0, likeNumber=75, createdTime=2019-10-03, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0141803814a, moduleTitle=Sci tranal med：BAFF-R靶向CAR T细胞疗法可克服B细胞恶性肿瘤的CD19抗原缺失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0141803814a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273323, encodeId=90e212e332399, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：B细胞IRF4表达不足通过增强肿瘤免疫逃逸加速CLL的进展, objectType=article, longId=179944, objectId=d6a11e9944a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6a11e9944a1, replyNumber=0, likeNumber=102, createdTime=2019-09-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6a11e9944a1, moduleTitle=Blood：B细胞IRF4表达不足通过增强肿瘤免疫逃逸加速CLL的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6a11e9944a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273322, encodeId=41e912e3322a6, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=伊布替尼治疗B细胞恶性肿瘤中国专家共识（2019年版）, objectType=article, longId=179896, objectId=248a1e9896b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=248a1e9896b0, replyNumber=0, likeNumber=29, createdTime=2019-09-24, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=248a1e9896b0, moduleTitle=伊布替尼治疗B细胞恶性肿瘤中国专家共识（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=248a1e9896b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273321, encodeId=bc4212e3321c6, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nat Commun：B细胞带来危机与转机，黑素瘤免疫疗法何去何从, objectType=article, longId=179861, objectId=018b1e9861c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=018b1e9861c0, replyNumber=0, likeNumber=71, createdTime=2019-09-24, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=018b1e9861c0, moduleTitle=Nat Commun：B细胞带来危机与转机，黑素瘤免疫疗法何去何从, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=018b1e9861c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273320, encodeId=060f12e332004, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=儿童成熟B细胞淋巴瘤诊疗规范（2019年版）, objectType=article, longId=179762, objectId=4ccd1e97623b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ccd1e97623b, replyNumber=0, likeNumber=50, createdTime=2019-09-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ccd1e97623b, moduleTitle=儿童成熟B细胞淋巴瘤诊疗规范（2019年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ccd1e97623b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273319, encodeId=6d5612e331957, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=回肠弥漫大B细胞淋巴瘤超声表现1例, objectType=article, longId=179721, objectId=b5a31e9721f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5a31e9721f9, replyNumber=0, likeNumber=73, createdTime=2019-09-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5a31e9721f9, moduleTitle=回肠弥漫大B细胞淋巴瘤超声表现1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5a31e9721f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273318, encodeId=51ed12e33186f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, objectType=article, longId=179701, objectId=85981e970172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85981e970172, replyNumber=0, likeNumber=96, createdTime=2019-09-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85981e970172, moduleTitle=J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85981e970172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273317, encodeId=7bbd12e3317db, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Nat commun：B细胞带来危机与转机，黑素瘤免疫疗法将何去何从？, objectType=article, longId=179664, objectId=29af1e9664e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29af1e9664e4, replyNumber=0, likeNumber=100, createdTime=2019-09-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29af1e9664e4, moduleTitle=Nat commun：B细胞带来危机与转机，黑素瘤免疫疗法将何去何从？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29af1e9664e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273316, encodeId=db3412e331617, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤, objectType=article, longId=179636, objectId=788e1e96369b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788e1e96369b, replyNumber=0, likeNumber=77, createdTime=2019-09-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788e1e96369b, moduleTitle=Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788e1e96369b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273315, encodeId=a2de12e3315c3, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=拉斯克奖背后的故事：T细胞B细胞发现与抗癌药赫赛汀的诞生, objectType=article, longId=179274, objectId=b8971e9274f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8971e9274f1, replyNumber=0, likeNumber=88, createdTime=2019-09-12, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8971e9274f1, moduleTitle=拉斯克奖背后的故事：T细胞B细胞发现与抗癌药赫赛汀的诞生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8971e9274f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273314, encodeId=f1dd12e331424, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变, objectType=article, longId=176755, objectId=ddc71e6755b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddc71e6755b1, replyNumber=0, likeNumber=82, createdTime=2019-08-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddc71e6755b1, moduleTitle=Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddc71e6755b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273313, encodeId=98e712e3313dc, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：依鲁替尼联合来那度胺和利妥昔单抗用于复发性/难治性非生发中心B细胞DLBCL的疗效可期, objectType=article, longId=176195, objectId=60091e619534, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60091e619534, replyNumber=0, likeNumber=101, createdTime=2019-07-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60091e619534, moduleTitle=Blood：依鲁替尼联合来那度胺和利妥昔单抗用于复发性/难治性非生发中心B细胞DLBCL的疗效可期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60091e619534)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273312, encodeId=526f12e33128f, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制, objectType=article, longId=175631, objectId=b3231e5631fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3231e5631fa, replyNumber=0, likeNumber=71, createdTime=2019-07-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3231e5631fa, moduleTitle=Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3231e5631fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273311, encodeId=e9c612e331125, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用, objectType=article, longId=168705, objectId=eb1e168e0594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb1e168e0594, replyNumber=0, likeNumber=69, createdTime=2019-06-20, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb1e168e0594, moduleTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb1e168e0594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273310, encodeId=db4e12e33100a, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀, objectType=article, longId=168636, objectId=b21a168636d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b21a168636d1, replyNumber=0, likeNumber=72, createdTime=2019-06-19, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b21a168636d1, moduleTitle=来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b21a168636d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273309, encodeId=d48f12e330955, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=B细胞淋巴瘤治疗：即使CAR-T疗法失败，还有双特异性抗体REGN1979, objectType=article, longId=168604, objectId=b8a016860474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8a016860474, replyNumber=0, likeNumber=82, createdTime=2019-06-18, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8a016860474, moduleTitle=B细胞淋巴瘤治疗：即使CAR-T疗法失败，还有双特异性抗体REGN1979, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8a016860474)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273308, encodeId=6b0512e3308ab, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=蔡清清教授：盘点弥漫大B细胞淋巴瘤研究进展, objectType=article, longId=168221, objectId=0e2216822192, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e2216822192, replyNumber=0, likeNumber=102, createdTime=2019-06-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e2216822192, moduleTitle=蔡清清教授：盘点弥漫大B细胞淋巴瘤研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e2216822192)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1273307, encodeId=80ef12e330785, content=<a href='/topic/show?id=310d383ef5' target=_blank style='color:#2F92EE;'>#B细胞#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V3）, objectType=article, longId=167558, objectId=09e316e558c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09e316e558c2, replyNumber=0, likeNumber=24, createdTime=2019-06-04, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09e316e558c2, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2019.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09e316e558c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

【2019 CSCO】国内白血病·淋巴瘤专场：聚焦淋巴瘤治疗前沿，BTK抑制剂在B细胞淋巴瘤中应用前景广阔

2019-10-05

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：Ublituximab联合Umbralisib治疗复发性/难治性B细胞NHL和CLL的安全性评估

2019-10-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Sci tranal med：BAFF-R靶向CAR T细胞疗法可克服B细胞恶性肿瘤的CD19抗原缺失

2019-10-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：B细胞IRF4表达不足通过增强肿瘤免疫逃逸加速CLL的进展

2019-09-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

伊布替尼治疗B细胞恶性肿瘤中国专家共识（2019年版）

2019-09-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nat Commun：B细胞带来危机与转机，黑素瘤免疫疗法何去何从

2019-09-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

儿童成熟B细胞淋巴瘤诊疗规范（2019年版）

2019-09-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

回肠弥漫大B细胞淋巴瘤超声表现1例

2019-09-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

J Gastroenterology：PD-L1表达在原发性胃和肠弥漫性大B细胞淋巴瘤中的预后影响

2019-09-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Nat commun：B细胞带来危机与转机，黑素瘤免疫疗法将何去何从？

2019-09-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：携带MYC和BCL2/BCL6重排的高级别B细胞淋巴瘤

2019-09-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

拉斯克奖背后的故事：T细胞B细胞发现与抗癌药赫赛汀的诞生

2019-09-12

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：弥漫性大B细胞淋巴瘤CD37基因免疫优势位点的高发突变

2019-08-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：依鲁替尼联合来那度胺和利妥昔单抗用于复发性/难治性非生发中心B细胞DLBCL的疗效可期

2019-07-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

Blood：基因组整体分析揭示原发性纵隔大B细胞淋巴瘤的主要致病机制

2019-07-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

来那度胺在弥漫性大B细胞淋巴瘤中的应用

2019-06-20

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

来那度胺在弥漫性大B细胞淋巴瘤中的应用继续闪耀

2019-06-19

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

B细胞淋巴瘤治疗：即使CAR-T疗法失败，还有双特异性抗体REGN1979

2019-06-18

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

蔡清清教授：盘点弥漫大B细胞淋巴瘤研究进展

2019-06-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#B细胞#

NCCN临床实践指南：B细胞淋巴瘤（2019.V3）

2019-06-04

科室
- - 订阅+
  - 更多科室
工具
服务